-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
esketamine
-
NICE’s evidence review of esketamine for treatment-resistant depression
After an appeal by Janssen (the pharmaceutical company that manufactures esketamine) in July, NICE reviewed the evidence they submitted again in a technology appraisal guidance (TAG) and recommended against its use for treatment-resistant depression. The TAG committee’s discussion is an...- cassava7
- Thread
- depression esketamine evidence review ketamine nice treatment-resistant depression
- Replies: 3
- Forum: Research methodology news and research